Healthcare AINVIDIA BioNeMo Locks In as Pharma AI Standard; Novo Nordisk Surges 24.9% on AI Licensing DealSalvado•Jun 27, 2026
Healthcare AINVIDIA's BioNeMo Locks In Eli Lilly and Thermo Fisher as Five Rivals Race for the Drug Discovery StackSalvado•May 27, 2026
Healthcare AINovo Nordisk Stock Jumps 24.9% as Pharma Pivots from Wet Labs to AI InfrastructureSalvado•May 13, 2026
Healthcare AINVIDIA Locks Down Drug Discovery AI Stack Through Lilly, Thermo Fisher PartnershipsSalvado•Apr 14, 2026
Healthcare AINVIDIA's BioNeMo Platform Drives Enterprise Drug Discovery AI Adoption Across Pharma GiantsSalvado•Apr 9, 2026
